DoD Peer Reviewed Alzheimer’s Transforming Research Award | HT942524PRARPTRRA

Opportunity Information: Apply for HT942524PRARPTRRA

The DoD Peer Reviewed Alzheimer's Transforming Research Award (TrRA) is a FY24 funding opportunity from the Department of the Army (USAMRAA) under the Peer Reviewed Alzheimer's Research Program (PRARP). It supports ambitious, well-designed research that can meaningfully reduce the risk of Alzheimer's disease and related dementias (AD/ADRD) or prevent their development, with a notable emphasis on risk reduction linked to traumatic brain injury (TBI) and/or military service. The program is looking for work that goes beyond incremental progress and instead delivers advances that could significantly speed up prevention and risk-reduction efforts while showing a clear path toward real-world impact on patient care and quality of life.

Projects funded through this mechanism are expected to tackle a major unmet need or a critical barrier holding the field back. The scope includes, but is not limited to, identifying AD/ADRD risk factors (such as environmental, genetic, epigenetic, or lifestyle factors), developing and implementing strategies to reduce risk and prevent cognitive problems after TBI or military service, and clarifying how social determinants of health shape risk and prevention outcomes. The announcement also calls for "informational" epidemiology, meaning studies designed to generate actionable insights about contributing factors and mechanisms rather than purely descriptive population summaries. In short, the goal is to produce knowledge that changes how the field understands risk and how prevention is carried out, especially for populations affected by military-related exposures and injuries.

A central requirement is that applications show strong alignment with the population the research is intended to benefit. Applicants must clearly explain how the study will be representative of that population and must demonstrate cultural competence throughout the research process. In this context, cultural competence means designing and conducting research in ways that reflect the lived realities, backgrounds, and needs of diverse groups, with the explicit aim of reducing health disparities and improving the relevance and uptake of research findings. This expectation is not treated as an add-on; it is framed as essential to producing high-quality, high-impact prevention research.

The award places heavy weight on rigor and strength of the overall research design. Preliminary data are required, reinforcing that the program expects teams to build from an existing foundation and use that base to move quickly toward more definitive, influential outcomes. The opportunity also signals that animal models are allowed only when their relevance to human health is well justified, reflecting a preference for translational value and practical relevance. Applications that propose small, stepwise advances without a compelling case for transforming the field are considered outside the intent of the mechanism.

Community collaboration is another defining feature. For any clinical research, partnering with community stakeholders is required, and it is strongly encouraged even for preclinical projects. The program uses "Community(ies)" to refer broadly to people living with AD/ADRD, family members, and care partners/caregivers, and it expects partnerships that are equitable and non-tokenistic. The intent is shared responsibility and shared ownership, where community partners help shape the project across key stages such as needs assessment, planning, intervention design, implementation, evaluation, and dissemination. The opportunity highlights approaches like community-based participatory research and participatory action research, emphasizing that research findings should be jointly interpreted and then translated into forms that communities can use, including interventions, practices, or policy changes.

Applicants also must include a plan to feed results back to the community. This requirement goes beyond standard academic dissemination and is meant to ensure that knowledge gained with public funds actively supports continued learning and practical benefit for the people most affected by dementia. The expectation is that results and outcomes are communicated in accessible, useful ways to the relevant communities, not only through journals and conferences.

The funding opportunity includes an optional Career Initiation or Transition (CIT) Partnership Option designed to build capacity in the AD/ADRD and military health research workforce. Under this option, two principal investigators can apply together: an Initiating PI and a Partnering PI, with either one eligible to be the CIT PI. A Career Initiation PI is an early-career investigator who is at least 3 years past their terminal degree and no more than 7 years into an independent position. A Career Transition PI can be at any career stage but must be new to the military health, TBI, or AD/ADRD fields, defined as having minimal publications in the relevant area. The partnering investigator must bring complementary expertise, and both PIs are expected to make substantive, distinct contributions to the science and the application materials. If funded, each PI is named on an individual award within the recipient organization(s), reflecting a structure that supports genuine co-leadership rather than a secondary mentorship role.

Administratively, this is a discretionary grant opportunity (Funding Opportunity Number HT942524PRARPTRRA; CFDA 12.420) with unrestricted eligibility and an original closing date of June 20, 2024. The notice indicates an expected number of awards of about five, and while an award ceiling is referenced, it is not specified in the provided text. Overall, the TrRA is positioned as a high-impact mechanism for teams that already have early evidence and a strong plan to deliver prevention-oriented breakthroughs in AD/ADRD, particularly where military service and TBI may influence risk, and where meaningful community partnership strengthens both the science and the real-world usefulness of the results.

• The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Peer Reviewed Alzheimer’s Transforming Research Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on 2024-03-25.
• Applicants must submit their applications by 2024-06-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 5 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for HT942524PRARPTRRA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: